These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10435857)

  • 1. Abdominal obesity increases overnight cortisol excretion.
    Duclos M; Corcuff JB; Etcheverry N; Rashedi M; Tabarin A; Roger P
    J Endocrinol Invest; 1999 Jun; 22(6):465-71. PubMed ID: 10435857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.
    Pasquali R; Cantobelli S; Casimirri F; Capelli M; Bortoluzzi L; Flamia R; Labate AM; Barbara L
    J Clin Endocrinol Metab; 1993 Aug; 77(2):341-6. PubMed ID: 8393881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration.
    Vicennati V; Pasquali R
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4093-8. PubMed ID: 11095438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids.
    Duclos M; Gatta B; Corcuff JB; Rashedi M; Pehourcq F; Roger P
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):447-54. PubMed ID: 11678826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women.
    Duclos M; Marquez Pereira P; Barat P; Gatta B; Roger P
    Obes Res; 2005 Jul; 13(7):1157-66. PubMed ID: 16076984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
    Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
    J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution.
    Pasquali R; Biscotti D; Spinucci G; Vicennati V; Genazzani AD; Sgarbi L; Casimirri F
    Clin Endocrinol (Oxf); 1998 May; 48(5):603-12. PubMed ID: 9666872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment: response of the hypothalamic-pituitary-adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes.
    Vicennati V; Ceroni L; Gagliardi L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3984-8. PubMed ID: 12161547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Sep; 22(9):1146-50. PubMed ID: 16108840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.
    Hautanen A; Räikkönen K; Adlercreutz H
    J Intern Med; 1997 Jun; 241(6):451-61. PubMed ID: 10497620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal (HPA) axis functioning in relation to body fat distribution.
    Rutters F; Nieuwenhuizen AG; Lemmens SG; Born JM; Westerterp-Plantenga MS
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):738-43. PubMed ID: 19769618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol secretion in relation to body fat distribution in obese premenopausal women.
    Mårin P; Darin N; Amemiya T; Andersson B; Jern S; Björntorp P
    Metabolism; 1992 Aug; 41(8):882-6. PubMed ID: 1640867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.
    Rosmond R; Dallman MF; Björntorp P
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1853-9. PubMed ID: 9626108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.
    Oguz Y; Oktenli C; Ozata M; Ozgurtas T; Sanisoglu Y; Yenicesu M; Vural A; Bulucu F; Kocar IH
    J Endocrinol Invest; 2003 Jul; 26(7):609-15. PubMed ID: 14594109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test.
    Viardot A; Huber P; Puder JJ; Zulewski H; Keller U; Müller B
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5730-6. PubMed ID: 16014408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.